🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I am excited to share that I will be staying at the University of Pittsburgh as an Assistant Professor to start a Sjogren's Center and translational research program. A special thanks to all of my mentors! PittRheum Magee-Womens Research Institute & Foundation Sjögren's Foundation PittDeptofMed Rheumatology Research Foundation

We're thrilled to announce our 2024 Award Recipients! Funding for these recipients will accelerate ground-breaking scientific discoveries in rheumatic disease research & address the workforce shortage to ensure patients have access to care. magazine.rheumresearch.org/2024-award-rec…

Check out the N&V in Nature Immunology by Inaki Sanz about Rebecca Elsner Mark Shlomchik Lab's recent paper on how B cell intrinsic IL-12 promotes EF and suppresses GC responses via an autocrine positive feedback loop with IFNg. nature.com/articles/s4159…

The American College of Rheumatology (ACR) is here to help you navigate diagnosis and treatment for patients with rheumatic disease. Visit rheumforprimarycare.org to view our clinical practice guidelines, information for patients, and more.

And here is a link to the articles: link.springer.com/book/10.1007/9…

Thank you Nature Reviews Nephrology for writing a Research Highlight about our paper! nature.com/articles/s4158…

Excited for the next five years of hosting JCI insight! Check out the recent editorial from the new Editor-in-Chief, our very own Oliver!👇 University of Pittsburgh Pitt Health Sciences

#RheumNews ➡️ Rachael Gordon MD, PhD, MD, PhD, PittRheum, recently started the first center at UPMC to comprehensively care for patients with #Sjögren’s disease and advance research for innovative therapies. Read more about the new center: go.upmc.com/3265sf27O

The Lupus Research Alliance and clinical research affiliate Lupus Therapeutics are excited to share positive news of the Phase 3 REGENCY clinical trial showing benefits of Gazyva® (obinutuzumab) in treating people with active #lupus nephritis (inflammation of the kidney

Congratulations to Rachael Gordon MD, PhD, PittRheum, recipient of American College of Rheumatology’s 2024 Distinguished Fellow Award, which will be presented during #ACR24 in November. 🏆

NEW EPISODE! Let’s roll up our sleeves & put #Sjögren’s disease into focus this week. We tackle diagnosis, treatment, advancements, & so much more with Sara McCoy, MD, PhD. LISTEN HERE → acr.tw/3Akmgjf

#ACR24

.PittRheum's Jeremy Tilstra, MD, PhD, and Rachael Gordon MD, PhD, were co-authors on a paper highlighting how targeting Myd88 or its upstream activators may be a viable therapeutic option for systemic lupus erythematosus. go.upmc.com/37213Nevi

Our own Rachael Gordon MD, PhD is highlighted in the newest edition of PittDeptofMed Code Blue and Gold! news.dom.pitt.edu/rachael-gordon…

I am officially a board certified rheumatologist!

Congratulations to Dr. Mehret Birru Talabi, who was recently promoted to Associate Professor of Medicine with tenure in the Division of Rheumatology and Clinical Immunology! 👏🎊👏

With positive ANA studies being very common, why did Mehmet Hocaoglu, MD feel this study needed to be done? His answer, HERE → acr.tw/42d7QN2 ACR_Journals

Sjogrens working group presents at OMERACT 2025! OMERACT Sjögren's Foundation